| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |